Takeda Ruling On Expert Standards To Ripple Beyond Actos
A California appellate court's finding that a plaintiffs expert didn't have to rule out all other possible causes of a man's bladder cancer besides Takeda Pharmaceutical Co. Ltd. drug Actos will...To view the full article, register now.
Already a subscriber? Click here to view full article